26 May 2013
Keywords: bayer, enters, generic, yasmin, deal, barr, after
Article | 30 June 2008
After an appeal court decision invalidated Bayer Schering Pharma's patent for the oral contraceptive Yasmin (drospirenone/ethinyl
estradiol) that was ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
7 July 2008
24 May 2013
© 2013 thepharmaletter.com